At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways

Summary: At a big cancer meeting called ASCO in Chicago, Dr. Brian Wolpin shared exciting new research. He presented a study on a drug called daraxonrasib for pancreatic cancer. The crowd was so moved that they gave him a long standing ovation right in the middle of his speech. Wolpin said it was hard not to cry, feeling like 20 years of hard work all came together in just 12 minutes.

For more details, see rssapp-statnews-com at statnews.com/2026/06/01/asco-news-day-4-merkel-cell-carcinoma-glp1s-grail/ (opens in new tab)